Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

LON/0QAH stock hub

LON/0QAH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QAHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

201.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QAH

In the news

Latest news · LON/0QAH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.9

P25 12.9P50 16.9P75 23.5

Trailing P/E29.8

P25 15.9P50 22.9P75 35.8

ROE18.9

P25 -54.2P50 2.1P75 13.7

ROIC21.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QAH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	74,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$233.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-05-10
Market cap	$201.9B
Price	$112
Price currency	USD
Rev Per Employee	673,059.94x
Sector	Healthcare
Sic	2834
Symbol	lon/0QAH
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.35%
EV Earnings	34.55x
EV/EBIT	12.98x
EV/EBITDA	10.64x
EV/FCF	21.87x
EV/Sales	4.84x
FCF yield	5.29%
Forward P/E	17.9x
P/B ratio	5.8x
P/E ratio	29.84x
P/S ratio	4.05x
PE Ratio10 Y	54.31x
PE Ratio3 Y	99.8x
PE Ratio5 Y	67.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	37.3%
EBITDA Margin	44.88%
FCF margin	21.46%
Gross margin	76.73%
Gross Profit	$38.2B
Gross Profit Growth	2.43%
Gross Profit Growth Q	2.18%
Gross Profit Growth3 Y	6.22%
Gross Profit Growth5 Y	10.9%
Net Income	$6.8B
Net Income Growth	-48.75%
Net Income Growth Years	2%
Net Income Growth3 Y	-11.82%
Net Income Growth5 Y	4.92%
Pretax Margin	17.68%
Profit Margin	13.59%
Profit Per Employee	$91,439
Profitable Years	14
ROA	12.58
Roa5y	11.18
ROCE	24.11
ROE	18.94
Roe5y	30.37
ROIC	21.18
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.85%
Cagr15y	15.27%
Cagr1y	45.53%
Cagr20y	10.23%
Cagr3y	1.39%
Cagr5y	10.82%
Div CAGR10	7.43%
Div CAGR3	1.49%
Div CAGR5	5.18%
EPS Growth	-48.02
EPS Growth Years	2
EPS Growth3 Y	-11.28
EPS Growth5 Y	5.25
FCF Growth	-17.16%
FCF Growth Q	149.74%
FCF Growth3 Y	7.82%
FCF Growth5 Y	16.21%
OCF Growth	-14.31%
OCF Growth Q	56.72%
OCF Growth10 Y	3.71%
OCF Growth3 Y	4.51%
OCF Growth5 Y	9.85%
Revenue Growth	2.89x
Revenue Growth Q	4.88x
Revenue Growth Quarters	3x
Revenue Growth Years	6x
Revenue Growth3 Y	4.36x
Revenue Growth5 Y	9.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$97.5B
Cash	$4.3B
Current Assets	$25.7B
Current Liabilities	$19.8B
Debt	$37.2B
Debt EBITDA	$1.64
Debt Equity	$1.07
Debt FCF	$3.48
Equity	$34.8B
Interest Coverage	16.11
Liabilities	$62.7B
Long Term Assets	$71.8B
Long Term Liabilities	$42.9B
Net Cash	$-32.9B
Net Cash By Market Cap	$-16.29
Net Debt EBITDA	$1.47
Net Debt Equity	$0.95
Net Debt FCF	$3.08
Tangible Book Value	$-1.1B
Tangible Book Value Per Share	$-0.44
WACC	4.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	2.42
Net Working Capital	$3.6B
Quick ratio	0.7
Working Capital	$6.1B
Working Capital Turnover	$5.41

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.79%
Dividend Growth	0.56%
Dividend Growth Years	4%
Dividend per share	$2.47
Dividend Years	23
Dividend Yield	2.2%
Ex Div Date	2026-03-16
Last Dividend	$0.64
Payout Frequency	Quarterly
Payout Ratio	92.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	234.76%
1Y total return	45.49%
200-day SMA	100.4
3Y total return	4.23%
50-day SMA	116.7
50-day SMA vs 200-day SMA	50over200
5Y total return	67.16%
All Time High	152.1
All Time High Change	-26.4%
All Time High Date	2024-05-17
All Time Low	0.44
All Time Low Change	25,196.11%
All Time Low Date	2017-11-28
ATR	3.46
Beta	0.2
Ch YTD	5.92
High	113.5
High52	125.1
High52 Date	2026-02-25
High52ch	-10.59%
Low	111.5
Low52	71.7
Low52 Date	2025-07-11
Low52ch	59.54%
Ma50ch	-4.12%
Price vs 200-day SMA	11.51%
RSI	42.8
RSI Monthly	56.6
RSI Weekly	53.57
Sharpe ratio	1.35x
Sortino ratio	2.46
Total Return	4%
Tr YTD	6.69
Tr15y	742.7%
Tr1m	-5.35%
Tr1w	-0.54%
Tr3m	-7.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$18.6B
Operating Income Growth	0.5
Operating Income Growth Q	1.06
Operating Income Growth3 Y	7.38
Operating Income Growth5 Y	17.25
Operating margin	37.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,465,769,316%
Net Borrowing	10,121,026,172
Shares Insiders	0.05%
Shares Institutions	80%
Shares Qo Q	-0.64%
Shares Yo Y	-1.79%
Short Ratio	2.79

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$10.1B
Average Volume	13,598.8x
Bv Per Share	14.07
CAPEX	$-2.9B
Ch10y	143.3
Ch15y	380.7
Ch1m	-5.35
Ch1w	-0.54
Ch1y	40.41
Ch20y	224.9
Ch3m	-8.41
Ch3y	-4.84
Ch5y	43.02
Ch6m	30.42
Change	0.12%
Change From Open	-0.08
Close	111.8
Days Gap	0.21
Depreciation Amortization	3,655,833,776
Dollar Volume	651,204.3
Earnings Date	2026-04-30
EBIT	$18.6B
EBITDA	$22.4B
EPS	$2.71
F Score	4
FCF	$10.7B
FCF EV Yield	4.57x
Financing CF	645,223,860
Fiscal Year End	December
Founded	1,891
Goodwill	15,829,965,634
Graham Number	40.33972
Graham Upside	-63.95
Income Tax	$2B
Investing CF	-17,012,099,520
Is Primary Listing	0
Last Earnings Date	2026-02-03
Last Report Date	2026-03-31
Lynch Fair Value	$18.75
Lynch Upside	-83.24
Ma150	106.3
Ma150ch	5.24%
Ma20	114.4
Ma20ch	-2.14%
Net CF	-2,524,854,870
Open	112
P FCF Ratio	18.89
P OCF Ratio	14.9
Payment Date	2026-04-07
Position In Range	21.29
Ppne	18,655,461,562
Price Date	2026-05-08
Price EBITDA	$9.03
Relative Volume	0.42x
Revenue	49,806,435,240x
SBC By Revenue	1.23x
Share Based Comp	613,417,050
Tax By Revenue	4.1x
Tax Rate	23.17%
Tr20y	601.19%
Tr6m	32.5%
Volume	5,819
Z Score	3.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QAH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$2.47 annual per share

Payout ratio

+92.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.2%

4 consecutive years of growth

Total shareholder yield

+4.0%

Next ex-dividend date: 2026-03-16

Performance

LON/0QAH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QAH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0QAH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.8

Neutral momentum band

Price vs 200-day MA

+11.5%

50/200-day relationship not available

Beta (5Y)

0.20

Less volatile than the market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QAH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QAH stock rating?

lon/0QAH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QAH analysis?

The full report lives at /stocks/lon/0QAH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QAH?

The latest report frames lon/0QAH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QAH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.